Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Scalp block for headache after aneurysmal subarachnoid hemorrhage in ICU patients

Official title: Efficacy of Scalp Block in Managing Post Subarachnoid Hemorrhage Headache in Critically Ill Patients. A Single Centre Randomized Controlled Trial

Run by Hamad Medical Corporation · NCT07307508 · Data updated 2026-11-12

We are testing whether a levobupivacaine scalp block added to standard pain medicines can reduce severe headache in adults in the ICU after aneurysmal subarachnoid hemorrhage treated endovascularly.

More Headache Disorders trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment22 (estimated)
SponsorHamad Medical Corporation
Industry-sponsored
Locations1 site (Doha)
StatusRecruiting
StartedOctober 22, 2025
Main results expectedJuly 30, 2026
Study endsDecember 30, 2026
Registry record updatedDecember 29, 2025
Trial IDNCT07307508 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 admitted to the SICU with aneurysmal subarachnoid hemorrhage who underwent endovascular aneurysm treatment, are neurologically stable/awake (GCS >13), and have no chronic headache, bleeding disorder, pregnancy, or allergy to local anesthetics.

Probably not a fit

Patients who had surgical clipping, non-aneurysmal hemorrhage, low consciousness (GCS ≤13 or WFNS 4–5), prolonged mechanical ventilation, chronic headache disorders, bleeding disorders, pregnancy, or local anesthetic allergy are excluded and unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center randomized controlled trial at Hamad Medical Corporation compares a levobupivacaine scalp block plus conventional analgesic therapy versus conventional analgesics alone for adults with aneurysmal subarachnoid hemorrhage treated by endovascular methods. Eligible participants are adults admitted to the surgical ICU who are awake and meet neurological stability criteria, while patients with surgical clipping, chronic headache disorders, bleeding disorders, pregnancy, or local anesthetic allergy are excluded. The intervention delivers regional scalp anesthesia and investigators will measure headache severity, opioid consumption, ICU course, and adverse events during hospitalization. Patients are randomly assigned to one of the two arms and treated according to standardized analgesic protocols.

Why it matters

Potential benefit: If successful, this approach could provide faster and stronger headache relief and reduce opioid use and ICU-related complications after aSAH.

How similar studies have gone: Small case series and observational reports have suggested scalp blocks can relieve post-SAH headache, but randomized controlled evidence is currently lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All adults \> 18 years who are admitted to the Surgical Intensive Care Unit (SICU) with a confirmed diagnosis of aneurysmal subarachnoid hemorrhage, undergoing endovascular treatment of the aneurysm (coiling/flow diversion).

Exclusion Criteria:

1. Patients with aSAH undergoing surgical craniotomy and aneurysmal clipping.
2. Non-aneurysmal subarachnoid or other intracranial hemorrhage forms (e.g., Intracerebral hemorrhage).
3. SICU admission Glasgow Coma Scale (GCS) of 13 or lower.
4. WFNS Score 4 / 5 or requiring mechanical ventilation for more than 24 hrs.
5. Patients with known allergy to local anesthetics.
6. Admission to ICU \> 7 days after hemorrhage.
7. Patients with a documented bleeding disorder.
8. Patients with a history of chronic headache disorder or migraine.
9. Pregnancy

Where it's running

  • Hamad Medical Corporation
    Doha, Qatar
    Recruiting

Study contacts

  • Principal investigator: Sohel Mohamed Ahmed, Consultant — Hamad Medical Corporation
  • Study coordinator: Sohel Mohamed Ahmed, Consultant
  • Email: SAhmed65@hamad.qa
  • Phone: +97450586481

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.